Piramal Pharma Limited (BOM:543635)
India · Delayed Price · Currency is INR 172.40
-1.80 (-1.03%)
At close: May 29, 2026
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 229.44 billion as of June 1, 2026. Its market cap has decreased by -16.70% in one year.
Market Cap
229.44B
Enterprise Value
272.63B
Revenue
88.69B
Ranking
n/a
PE Ratio
n/a
Stock Price
172.40
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 229.44B, an increase of 1.19%. That is a compound annual growth rate of 0.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 229.44B | 0.34% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 571.12B |
| GlaxoSmithKline Pharmaceuticals | 374.17B |
| J. B. Chemicals & Pharmaceuticals | 348.81B |
| AstraZeneca Pharma India | 216.79B |
| Granules India | 191.37B |
| Rubicon Research | 165.67B |
| Jubilant Pharmova | 157.38B |
| Caplin Point Laboratories | 154.31B |